Prestige Consumer Healthcare (PBH) Total Non-Current Liabilities (2013 - 2025)

Prestige Consumer Healthcare's (PBH) quarterly Total Non-Current Liabilities came in at $1.7 billion in Q4 2025, up 8.04% year-on-year from $1.5 billion in Q4 2024, and up 2.95% quarter-over-quarter from $1.6 billion in Q3 2025.

Prestige Consumer Healthcare (PBH) Total Non-Current Liabilities (2013 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Total Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $1.7 billion for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 8.04% year-over-year to $1.7 billion in Q4 2025; TTM through Dec 2025 was $1.7 billion, a 8.04% increase from a year earlier, with the FY2025 full-year figure at $1.6 billion, down 5.57% from the prior year.
  • Total Non-Current Liabilities improved to $1.7 billion in Q4 2025 per PBH's latest filing, from $1.6 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $2.2 billion in Q3 2021 and bottomed at $1.5 billion in Q4 2024.
  • The 5-year median for Total Non-Current Liabilities is $1.8 billion (2023), against an average of $1.8 billion.
  • Across the five-year window, Total Non-Current Liabilities retreated 15.76% in 2023 and climbed 8.04% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $2.1 billion in 2021, then slipped by 3.69% to $2.1 billion in 2022, then slipped by 15.76% to $1.7 billion in 2023, then dropped by 11.23% to $1.5 billion in 2024, then rose by 8.04% to $1.7 billion in 2025.
  • Per Business Quant, the three latest PBH Total Non-Current Liabilities figures stand at $1.7 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.6 billion (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Prestige Consumer Healthcare 2.34 Bn 2.28 Bn 157.37 Mn 1.66 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.66 Bn
Sep 30, 2025 1.61 Bn
Jun 30, 2025 1.57 Bn
Mar 31, 2025 1.56 Bn
Dec 31, 2024 1.54 Bn
Sep 30, 2024 1.58 Bn
Jun 30, 2024 1.62 Bn
Mar 31, 2024 1.65 Bn
Dec 31, 2023 1.73 Bn
Sep 30, 2023 1.79 Bn
Jun 30, 2023 1.86 Bn
Mar 31, 2023 1.90 Bn
Dec 31, 2022 2.05 Bn
Sep 30, 2022 2.05 Bn
Jun 30, 2022 2.09 Bn
Mar 31, 2022 2.09 Bn
Dec 31, 2021 2.13 Bn
Sep 30, 2021 2.21 Bn
Jun 30, 2021 2.13 Bn
Mar 31, 2021 2.06 Bn